|
GSPT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.0782000000017E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.392700E-04 |
| Normal-vs-Stage2 |
1.082580E-01 |
| Normal-vs-Stage3 |
1.96870000002125E-06 |
| Normal-vs-Stage4 |
2.73859999999626E-06 |
| Stage1-vs-Stage2 |
2.017800E-01 |
| Stage1-vs-Stage3 |
4.955500E-02 |
| Stage1-vs-Stage4 |
2.705900E-02 |
| Stage2-vs-Stage3 |
1.324080E-02 |
| Stage2-vs-Stage4 |
1.261960E-02 |
| Stage3-vs-Stage4 |
7.501400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65017000000045E-05 |
| Normal-vs-AfricanAmerican |
1.744180E-02 |
| Normal-vs-Asian |
1.996110E-03 |
| Caucasian-vs-AfricanAmerican |
7.275000E-01 |
| Caucasian-vs-Asian |
9.670200E-01 |
| AfricanAmerican-vs-Asian |
7.946200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.69879999998035E-06 |
| Normal-vs-Female |
2.244700E-04 |
| Male-vs-Female |
1.584830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.321600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.81430000004246E-06 |
| Normal-vs-Age(61-80Yrs) |
1.683630E-03 |
| Normal-vs-Age(81-100Yrs) |
5.441800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.009800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.642200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.487400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.148400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.561800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.957000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.037800E-02 |
| Classical-VS-Follicular |
1.962420E-01 |
| Classical-VS-Other |
1.631970E-01 |
| Classical-VS-Normal |
4.28330000000754E-05 |
| Tall-VS-Follicular |
1.484010E-02 |
| Tall-VS-Other |
6.056200E-01 |
| Tall-VS-Normal |
5.65160000000064E-05 |
| Follicular-VS-Other |
1.451820E-01 |
| Follicular-VS-Normal |
4.603900E-02 |
| Other-VS-Normal |
5.304800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.041400E-04 |
| Normal-vs-N1 |
7.56789999556418E-08 |
| N0-vs-N1 |
3.658700E-03 |
|
|
